Piper Sandler: Upgraded the Design Therapeutics (DSGN.US) rating from neutral to incremental, and adjusted the target price from $6.00 to $12.00.
Piper Sandler：上调Design Therapeutics(DSGN.US)评级，由中性调整至增持评级, 目标价由6.00美元调整至12.00美元。
Piper Sandler: Upgraded the Design Therapeutics (DSGN.US) rating from neutral to incremental, and adjusted the target price from $6.00 to $12.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated